Migration of the left atrial appendage closure device to the aorta

Susana González-Suárez1, José Carlos Sureda Barbosa2, María Sol Siliato Robles2

  • 1Department of Surgery, Department of Anesthesiology and Intensive Care, Cardiovascular diseases Research Group, Universitat Autònoma de Barcelona, Unitat Docent Vall d´Hebron, Vall d´Hebron University Hospital, Vall d´Hebron Institut de Recerca (VHIR), Passeig Vall d´Hebron 119-129, Barcelona, 08035, Spain. susana.gonzalez@uab.cat.

Insights

Left atrial appendage closure is an alternative to anticoagulation but can cause complications. Device migration led to severe aortic insufficiency, necessitating emergency cardiac surgery for removal.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Left atrial appendage (LAA) closure offers an alternative to long-term anticoagulation for patients with atrial fibrillation and contraindications to blood thinners, such as recurrent bleeding.
  • Percutaneous LAA closure devices aim to prevent stroke by sealing the LAA, a common source of emboli.

Observation:

  • A patient requiring LAA closure due to contraindications for anticoagulation therapy developed severe aortic insufficiency.
  • The complication was directly attributed to the migration of the implanted LAA closure device.

Findings:

  • Device migration is a rare but serious complication of percutaneous LAA closure.
  • Severe aortic insufficiency resulted from the displaced LAA closure device, posing an immediate threat to the patient's life.

Implications:

  • This case highlights the potential risks associated with LAA closure devices and the need for careful patient selection and monitoring.
  • Urgent surgical intervention may be required to manage device-related complications, emphasizing the importance of a multidisciplinary approach in managing atrial fibrillation patients.
  • Further research into device design and implantation techniques may be warranted to minimize migration risks.

Related Concept Videos

Location and Orientation of the Heart01:13

Location and Orientation of the Heart

The human heart, despite its modest size and weight, is an organ of remarkable strength and endurance. Roughly the size of a fist, the heart weighs between 250 and 350 grams and is nestled within the mediastinum, the medial cavity of the thorax. It extends obliquely for about 12 to 14 cm, resting on the superior surface of the diaphragm. The heart is positioned anterior to the vertebral column and posterior to the sternum, with two-thirds of its mass lying to the left of the midsternal line.
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...